home page | Catalogue table of contents |
| How to order | WHO sales agents | Contact information |
Updated 5 April 2000
ATC (Anatomical Therapeutic Chemical)
WHO Collaborating Centre for Drug Statistics Methodology
P.O. Box 100 Veitvet
N-0518 Oslo 5, Norway
Tel.: (47 22) 169 600; Fax: (47 22) 169 818
Air pollution, air quality
The 1988 edition of Air Quality Guidelines for Europe is out-of-print. New guidelines are in preparation but will not be available until late-1999.
An interim document is available on request from firstname.lastname@example.org:
Update and Revision of the Air Quality Guidelines for Europe, 1995, 29 pages, document code EUR/ICP/EHAZ 94 05/PB01
Click here to view the interim guidelines online.
Bovine spongiform encephalopathy, "mad cow disease", new variant of CJD
Click here to view recent WHO reports and fact sheets about BSE.
Cancer Treatment: WHO Recommendations for Grading of Acute and Subacute Toxicity
Reporting the Results of Cancer Treatment (Cancer 47:
This WHO report gives recommendations for standardized approaches to the recording of baseline data relating to the patient, the tumor, laboratory and radiologic data, the reporting of treatment, grading of acute and subacute toxicity, reporting of response, recurrence and disease-free interval, and reporting results of therapy. Though old, the article is still frequently requested and quoted.
Cannabis: A Health Perspective and Research Agenda
WHO Expert Working Group on Health Effects of Cannabis Use
WHO, 1997, 49 pages
Requests for copies should be sent to email@example.com
Please note that the background papers
prepared for the working group are being published by:
Addiction and Mental Health Services Corporation
33 Russell St
Email address for further information: firstname.lastname@example.org
These papers, which compare cannabis with other drugs, express the views of the authors, and not of WHO.
Related WHO press release
Distributed by FAO, Distribution and Sales
00100 Rome, Italy
Fax: (+39 6) 5225 3360
DDD (Defined Daily Dose) for pharmaceuticals and vitamins
Available from WHO Collaborating Centre for Drug Statistics Methodology
P.O. Box 100 Veitvet
N-0518 Oslo 5, Norway
Fax: (+47 22) 169 818
Drug Dictionary, Adverse Reaction Terminology (WHO-ART) and DD Access
Uppsala Monitoring Centre, Stora Torget 3 S-753 20 Uppsala
Tel: +46 18 65 60 60 Fax: +46 18 65 60 80
Drugs, generic names, International Nonproprietary Names for Pharmaceutical Substances
The most recent cumulative list is International Nonproprietary Names (INN) for Pharmaceutical Substances, Cumulative List No. 9
Newly proposed names are regularly published in WHO Drug Information.
A new cumulative list is now in press and should be available in mid-1996.
One useful Internet site for downloading EpiInfo and associated software, such as EpiMap, tutorials, is the United States Centers for Disease Control http://www.cdc.gov/epo/epi/epiinfo.htm
Click here for further information about EpiInfo.
Global Burden of Disease and Injury Series
Volume 1: The Global Burden of Disease: A comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020
C.J.L. Murray and A.D. Lopez
Harvard University Press, 1996, US $26.95
Quantifies the global burden of disease and injury, taking into account death as well as disability and ill-health, and allowing comparisons across geographic regions, age groups and sexes. The volume also explores the theoretical and practical bases and limits of health status indicators, providing a comprehensive account of the ways in which medical and public health practitioners describe and compare health states.
Volume 2: Global Health Statistics
edited by C.J.L. Murray and A.D. Lopez
Harvard University Press, 1996, US $26.95
Provides statistics on death and ill-health for the world's 240 most important diseases and injuries, allowing comparisons across geographic regions, age-groups and sexes.
Books in this 10-volume series can be ordered from:
Harvard University Press
79 Garden Street
Cambridge, MA 02138
Fax: 1-800-962-4983 (USA & Canada)
Fax: 617 495 8924 (International)
International Prostate-Symptom Score (I-PSS)
The Second International Consultation on Benign Prostatic Hyperplasia, Paris / June 27-30, 1993, ISBN 1 898452 05 9
Published by Scientific Communication International Ltd.
P.O. Box 490
Jersey JE4 8WZ, Channel Islands
International Certificates of Vaccination
This booklet reproduces the model certificate, as prescribed by the International Health Regulations, for recording vaccination or revaccination against yellow fever and other vaccinations recommended or advised by WHO. The booklets are sold at cost price, including despatch by surface mail; prices listed apply only to orders sent directly to WHO. Orders for 5,000 copies or more can be overprinted with the name of the distributing agency at cost.
Prices (bilingual English/French)
50 copies: Swiss francs 10.-/US $9.00
100 copies: Swiss francs 20.-/US $18.00
500 copies: Swiss francs 95.-/US $90.00
1100 copies: Swiss francs 180.-/US $162.00
5000 copies: Swiss francs 850.-/US $765.00
50000 copies: Swiss francs 8000.-/US $7200.00
Direct fax for orders: +41 22 791 48 57 | Email for orders: email@example.com
International Histological Classification of Tumours
The World Health Organization
Classification of Tumours series also called the "Blue Books
series" replaces the WHO International Histological Classification of
Tumours. This new series is published by the International Agency for Research
on Cancer. To view the recent books published in this series, please click on
this link: http://www.who.int/dsa/cat98/can8.htm
Former second editions of the WHO International Histological Classification of Tumours series were produced by:
Springer Verlag Berlin
P.O. Box 31 13 40
Tel: +49 30 82787 0
Fax: +49 30 82787 301
INTOX software (a package for poison information centres to help prevent poisoning, and to save lives and minimize damage to health from toxic exposures)
Canadian Centre for Occupational Health and Safety (CCOHS)
250 Main Street East Hamilton
Ontario, Canada L8N 1H6
Phone: (905) 570 8094
Fax: (905) 572 2206
Investing in Health Research and Development: Ad hoc committee on health research relating to future intervention options
WHO 1996, 116 pages + annexes
Document code: TDR/GET/96.1
Distributed on request: firstname.lastname@example.org
WHO MONICA (Monitoring trends in cardiovascular diseases) project
Internet site for more information: http://www.ktl.fi/monica/
Obesity: Preventing and Managing the Global Epidemic
Report of a WHO Consultation on Obesity, June 1997
1998, 276 pages
This interim report is now completely out of stock. The report is scheduled for formal publication, towards the end of 1999, in the WHO Technical Report Series. Click here to view the Executive Summary of this report.This report records the conclusions and recommendations of a major WHO consultation convened to consider the alarming global epidemic of obesity, assess the magnitude of associated public health problems, and map out strategies for prevention and control. Interventions at both the population level and in individual patients are described in detail. Reflecting the consensus reached by over 30 leading experts, the report also looks at the causes and costs of obesity in developing as well as industrialized countries, and in children as well as adults and presents a coherent system, based on the Body Mass Index, for assessing and classifying overweight and obesity.
Concerning the management of individual patients, the report offers advice on the pharmacological treatment of obesity, explains the principles of drug therapy, and reviews several promising new drugs which may soon be approved for marketing. Other strategies evaluated include dietary management, physical activity and exercise programmes, behaviour modification, and gastric surgery.
The report has eleven chapters presented in five parts. Part one, on defining the problem, examines the definition and classification of obesity and presents up-to-date regional data on the prevalence of obesity. Secular trends are also reported. Part two considers the true costs of obesity in terms of both physical and mental health and the human and financial resources being diverted to deal with this disease and its related health consequences. Chapters in part three examine the etiological factors implicated in weight gain and obesity. While most of the information about risk factors comes from studies in developed countries, findings have worldwide relevance for predicting the impact in developing countries.
Against this background, the fourth and most extensive part establishes the foundation for a comprehensive strategy involving health services and public health policies for preventing and managing obesity. Chapters review data on the effectiveness of available strategies, establish basic principles for prevention and management, define priority areas for interventions, and evaluate currently available treatments for individual patients. Special issues in the management of obesity in childhood and adolescence are also considered. The report concludes with a summary of the many important conclusions reached during the consultation and a discussion of areas where further research is urgently needed. Criteria for evaluating commercial institutions involved in weight loss are set out in an annex.
The Ottawa Charter was developed and adopted in November 1986 by an international conference organized jointly by the World Health Organization, Health and Welfare Canada and the Canadian Public Health Association. The text of the Charter was published in Health promotion, 1986, 1 (4): iii-v, The Charter is reproduced as an annex in Health Promotion: An Anthology and Health Promotion in the Workplace. Click here to view the full text of the Charter.
Quality of Life documentation
WHO has published a number of documents on quality of life assessment (WHOQOL). Further information is available from email@example.com
Also important is The World Health Organization Quality of Life Assessment (WHOQOL): Position Paper from the WHO. Soc. Sci. Med. Vol. 41, No. 10, pp.1403-1409, 1995.
WHONET software (program for the management of antimicrobial susceptibility data for any medical centre and to link such centres into a surveillance network)
Available on request from the WHO Collaborating Center for Surveillance of Antimicrobial Resistance, Microbiology
Brigham and Women's Hospital
Boston, MA 02115, USA